Most Read Articles
Dr. Joseph Delano Fule Robles, 6 days ago

A recent study conducted by The University of Hong Kong (HKU) revealed that long-term use of proton pump inhibitors (PPIs) is associated with a significantly increased risk of gastric cancer even in patients who have had Helicobacter pylori eradicated. 

5 days ago
The 5-year survival rates for human papillomavirus (HPV)-associated cancers vary greatly according to age and race, with Caucasians and younger patients tending to have better survival, according to a recent US study.
6 days ago
High levels of marijuana exposure appear to not be longitudinally associated with prevalent albuminuria and substantial changes in estimated glomerular filtration rate by cystatin C (eGFRcys), a recent US epidemiological study has shown.
5 days ago
Men with breast cancer have tumours that are typically of the human epidermal growth factor receptor 2-negative Luminal B subtype and positive for oestrogen receptor, progesterone receptor and androgen receptor, according to the results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program study.

Bladder training video not inferior to urotherapy for bladder/bowel dysfunction

17 Mar 2017

The bladder training video appears to be as effective as standard urotherapy in reducing bladder/bowel symptoms in children, according to a recent study.

“The video allows families to have free access to independently review bladder training concepts as often as necessary,” researchers said.

To assess the effectiveness of an animated bladder training video, a noninferiority randomized, controlled trial was performed involving patients (aged 5 to 10 years) who scored >11 on the bladder/bowel Vancouver questionnaire. Children with vesicoureteral reflux, neuropathic bladder, learning disabilities, recent urotherapy or primary nocturnal enuresis were excluded from analysis.

Researchers randomized patients to receive either standard urotherapy or watch a bladder training video in clinic using centralized blocked randomization schemes. Then, they assessed bladder/bowel symptoms at baseline and 3-month follow-up by intent-to-treat analysis.

A sample size of 150 patients ensured a 3.5 difference in mean symptomology scores between the groups, which was accepted as the noninferiority margin.

Of the enrolled patients, a total of 143 (95 percent) completed the trial, five (4 percent) were lost to follow-up and 2 (1 percent) withdrew from the study. Baseline characteristics between the two groups were similar.

Baseline mean symptomology score was for 19.9 for the bladder training video and 19.7 for standard urotherapy. The mean symptomology scores at 3 months were reduced to 14.1 and 13.8 for the bladder training video and standard urotherapy, respectively (p=0.54). The mean difference was 0.6 (95 percent CI, ‒1.4 to ‒2.6).

“The upper 95 percent CI limit of 2.6 did not exceed the preset 3.5 noninferiority margin,” according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 6 days ago

A recent study conducted by The University of Hong Kong (HKU) revealed that long-term use of proton pump inhibitors (PPIs) is associated with a significantly increased risk of gastric cancer even in patients who have had Helicobacter pylori eradicated. 

5 days ago
The 5-year survival rates for human papillomavirus (HPV)-associated cancers vary greatly according to age and race, with Caucasians and younger patients tending to have better survival, according to a recent US study.
6 days ago
High levels of marijuana exposure appear to not be longitudinally associated with prevalent albuminuria and substantial changes in estimated glomerular filtration rate by cystatin C (eGFRcys), a recent US epidemiological study has shown.
5 days ago
Men with breast cancer have tumours that are typically of the human epidermal growth factor receptor 2-negative Luminal B subtype and positive for oestrogen receptor, progesterone receptor and androgen receptor, according to the results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program study.